CIK 0001944552 · Non-accelerated filer<br>Emerging growth company
Adlai Nortye Group Ltd.
Sign in to watch- Ticker
- ANL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Singapore
- Entity type
- other
- Phone
- 848-230-7430
- Business address
- 77 ROBINSON ROAD, #20-01, ROBINSON 77, SINGAPORE, Singapore, 068896
- Former names
- Adlai Nortye Ltd.
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Open-market sale Director sold 10,214 shares at an average $15.99 ($163,275)
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Open-market sale Director sold 5,000 shares at $16.63 ($83,150)
- 144 Insider Sale of Securities
- EFFECT Other Notice of Effectiveness
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- 6-K Event Report of Foreign Issuer
- 4 Open-market sale CFO sold 11,667 shares at an average $14.11 ($164,635)
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
Page 1 of 6 · 114 filings